BEDFORD, Mass., Jan. 30 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference being held February 5-7, 2008 at the Grand Hyatt Hotel in New York, NY.
Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, February 5, 2008 at 1:40 p.m. Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of
premium diagnostics, medical imaging systems and surgical products
dedicated to serving the healthcare needs of women. Hologic leads the
industry in digital mammography systems and offers the most advanced
technology for breast imaging and breast biopsy. Hologic's core business
units are focused on breast health, diagnostics, GYN surgical, and skeletal
health. Hologic provides a comprehensive suite of technologies with
products for mammography and breast biopsy, radiation treatment for
early-stage breast cancer, cervical cancer screening, treatment for
menorrhagia, osteoporosis assessment, preterm birth risk assessment, and
mini C-arm for extremity imaging. For more information visit
Contact: Glenn P. Muir
Executive Vice President and CFO
Director, Investor Relations
|SOURCE Hologic, Inc.|
Copyright©2008 PR Newswire.
All rights reserved